drugset / Trial / NCT03106519

Liposome Bupivacaine for WRIST Blocks

NCT03106519

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Treatment of Dupuytren's contracture requires multiple injections into the palm of the hand to weaken the cords, followed by rupture of the strands 2 days later. Anesthesia is required for both phases of treatment. It is hypothesized that extended-release liposome bupivacaine prolongs nerve blockade of the wrist allowing patients to undergo this 2-part regimen with less pain.

Timeline

Start
2017-01-02
Primary completion
2017-06-28
Completion
2017-10-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 2.5 ml Other
Subject Bupivacaine Other / unclassified 5 ml Other
Subject Bupivacaine Other / unclassified 7.5 ml Other

Indications